Pure Global
NCT05866744

Effects of Time-restricted Hypocaloric Diet in Patients With NAFLD

Effects of a Time-restricted Hypocaloric Mediterranean Diet in Patients With Non-alcoholic Fatty Liver Disease on Glucose Metabolism (CHRONO-NAFLD Project)
Agricultural University of Athens·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Non-Alcoholic Fatty Liver Disease
Drug/Device/Intervention
Early Time-Restricted Feeding Plus Hypocaloric Mediterranean Diet
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Agricultural University of Athens
Location
Athens,Athens, Greece
Timeline & enrollment
Phase
N/A
Start date
May 08, 2023
End date
Jul 30, 2024
Enrollment
54 participants
Primary outcome

Change in blood glucose concentrations

Summary

The effects of a time-restricted hypocaloric Mediterranean type diet compared to a
 conventional hypocaloric Mediterranean type diet on blood glucose metabolism and liver
 steatosis in people with non-alcoholic fatty liver disease will be investigated.

ICD-10 classifications
Alcoholic fatty liverAlcoholic liver disease, unspecifiedAlcoholic liver diseaseLiver disease, unspecifiedAlcoholic cirrhosis of liver
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05866744
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05866744 through Pure Global AI's free database. This phase not specified trial is sponsored by Agricultural University of Athens and is currently Recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.